Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,224 | 2,640 | 15,261 | 468 | 1,022 |
| Cost of Goods | 930 | N/A | N/A | N/A | N/A |
| Gross Profit | 294 | 2,640 | 15,261 | 468 | 1,022 |
| Operating Expenses | 14,763 | 14,119 | 16,832 | 11,544 | 11,734 |
| Operating Income | -13,539 | -11,479 | -1,571 | -11,076 | -10,712 |
| Other Income | -330 | -3,369 | 2,554 | 3,046 | 949 |
| Pre-tax Income | -13,869 | -14,848 | 983 | -8,030 | -9,763 |
| Income Tax | 71 | 67 | 47 | 76 | 59 |
| Net Income Continuous | -13,940 | -14,915 | 936 | -8,106 | -9,822 |
| Net Income | $-13,940 | $-14,915 | $936 | $-8,106 | $-9,822 |
| EPS Basic Total Ops | -0.53 | -0.58 | 0.04 | -0.31 | -0.38 |
| EPS Basic Continuous Ops | -0.53 | -0.57 | 0.04 | -0.31 | -0.38 |
| EPS Diluted Total Ops | -0.53 | -0.58 | 0.04 | -0.31 | -0.38 |
| EPS Diluted Continuous Ops | -0.53 | -0.57 | 0.04 | -0.31 | -0.38 |
| EBITDA(a) | $-13,697 | $-11,477 | $-1,507 | $-10,870 | $-10,337 |